#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Colorectal cancer Dementia Alzheimer's type Ovarian cancer Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Antithrombin III deficiency Thymic carcinoma Anaplastic large cell lymphoma T- and null-cell types Congenital cystic kidney disease Meningitis meningococcal Neurotrophic keratopathy Hereditary spastic paraplegia Cutaneous lupus erythematosus White matter lesion Von Willebrand's disease Albright's disease Ewing's sarcoma metastatic Rett syndrome Vascular malformation Rosai-Dorfman syndrome More trials…

    Learn about Rare Diseases

    Combined immunodeficiency – Basic Information Mantle cell lymphoma stage III – Basic Information Rhabdomyosarcoma recurrent – Life with Disease Angelman’s syndrome Prolymphocytic leukaemia – Treatment Myxofibrosarcoma – Life with Disease Primary immunodeficiency syndrome – Basic Information Lymphatic malformation – Treatment Short-bowel syndrome – Diagnostics Lymphangioma – Trials in Disease More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Setrusumab Calcitriol Pehero Zoledronic Acid Monohydrate Ide397 Paroxetine Hydrochloride Linperlisib Basiliximab Metoprolol Tartrate Pimozide Mk-6194 Azd8205 Ranitidine Albiglutide Nortriptyline Lixisenatide Nebivolol Iopromide BIIB115 Ziltivekimab More therapies…

    Learn about Your Condition

    Cutaneous sarcoidosis Heparin resistance Osteomyelitis acute Sarcoidosis Diffuse large B-cell lymphoma Aplasia pure red cell Gastrointestinal disorder Cachexia Follicular lymphoma Thrombocytosis Macular oedema Left ventricular dysfunction Lung disorder Hypopituitarism Herpes simplex reactivation More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Pulmonary arterial hypertension

  • Study on Seralutinib for Treating Pulmonary Arterial Hypertension in Patients

    Not recruiting

    3 1
    Investigated Diseases:
    • Pulmonary arterial hypertension
    Investigated Drugs:
    • Seralutinib
    Austria Belgium Czechia Denmark France Germany +10

  • Study on Selexipag and Bosentan for Children with Pulmonary Arterial Hypertension

    Not recruiting

    3 1 1
    Investigated Diseases:
    • Pulmonary arterial hypertension
    Investigated Drugs:
    • Selexipag
    • Bosentan
    Belgium Bulgaria Finland France Germany Hungary +7

  • Study on the Effects of MK-5475 for Adults with Pulmonary Arterial Hypertension

    Not recruiting

    4 1
    Investigated Diseases:
    • Pulmonary arterial hypertension
    Investigated Drugs:
    • 3-(4-{(5S)-4-Amino-2-[6-Chloro-1-(3,3,4,4,4-Pentafluorobutyl)-1H-Indazol-3-Yl]-5-Methyl-6-Oxo6,7-Dihydro-5H-Pyrrolo[2,3-D]Pyrimidin-5-Yl}Phenyl)Propanoic Acid
    Belgium France Germany Greece Italy Poland +1

  • Study of AZD3427 for Patients with Heart Failure and Pulmonary Hypertension from Left Heart Disease

    Not recruiting

    2 1
    Investigated Diseases:
    • Cardiac failure
    • Pulmonary arterial hypertension
    Investigated Drugs:
    • Azd3427
    Austria Czechia Denmark Germany Italy The Netherlands +3

  • Study to Determine Safe Doses of Selexipag for Children with Pulmonary Arterial Hypertension

    Not recruiting

    2 1 1
    Investigated Diseases:
    • Pulmonary arterial hypertension
    Investigated Drugs:
    • Selexipag
    France Germany Hungary

  • Study on the Safety and Effects of Riociguat for Children Aged 6 to 17 with Pulmonary Arterial Hypertension

    Not recruiting

    3 1 1
    Investigated Diseases:
    • Pulmonary arterial hypertension
    Investigated Drugs:
    • Riociguat
    Germany Italy
Previous Page
1 … 4 5 6 7
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!